RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+18.53%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.06B
AUM Growth
+$1.06B
(+5.4%)
Cap. Flow
-$43.2M
Cap. Flow
% of AUM
-4.09%
Top 10 Holdings %
Top 10 Hldgs %
34.88%
Holding
95
New
10
Increased
31
Reduced
41
Closed
11
Top Buys
| 1 |
Cigna
CI
|
$32.7M |
| 2 |
Elevance Health
ELV
|
$29.3M |
| 3 |
Becton Dickinson
BDX
|
$28.7M |
| 4 |
Penumbra
PEN
|
$9.71M |
| 5 |
Merck
MRK
|
$9.37M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$24.7M |
| 2 |
Medtronic
MDT
|
$23.2M |
| 3 |
Eli Lilly
LLY
|
$18.5M |
| 4 |
Humana
HUM
|
$17.9M |
| 5 |
Danaher
DHR
|
$16.7M |
Sector Composition
| 1 | Healthcare | 99.69% |
| 2 | Industrials | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Relay Therapeutics
RLAY
$709M
| $1.91M | 0.18% |
230,000
-160,000
| -41% | -$1.33M |
|
|
IGMS
77
DELISTED
IGM Biosciences
IGMS
| $1.88M | 0.18% |
195,000
-5,000
| -3% | -$48.3K |
|
78
Bruker
BRKR
$4.45B
| $1.88M | 0.18% |
20,000
+4,000
| +25% | +$376K |
|
79
TG Therapeutics
TGTX
$5.03B
| $1.88M | 0.18% |
123,500
-36,500
| -23% | -$555K |
|
80
Intellia Therapeutics
NTLA
$1.26B
| $1.32M | 0.13% |
48,000
-2,000
| -4% | -$55K |
|
81
Amgen
AMGN
$153B
| $1.21M | 0.11% |
4,250
-250
| -6% | -$71.1K |
|
82
Bio-Techne
TECH
$8.3B
| $1.13M | 0.11% |
16,000
| – | – |
|
83
Acadia Healthcare
ACHC
$2.15B
| $1M | 0.09% |
12,624
-6,000
| -32% | -$475K |
|
84
Repligen
RGEN
$6.54B
| $920K | 0.09% |
5,000
-5,000
| -50% | -$920K |
|
85
CVS Health
CVS
$93B
| – | – |
-137,500
| Closed | -$10.9M |
|
86
Evolent Health
EVH
$1.11B
| – | – |
-230,000
| Closed | -$7.6M |
|
87
Health Catalyst
HCAT
$228M
| – | – |
-300,000
| Closed | -$2.78M |
|
|
88
Humana
HUM
$37.5B
| – | – |
-39,083
| Closed | -$17.9M |
|
89
Labcorp
LH
$22.8B
| – | – |
-15,000
| Closed | -$3.41M |
|
90
Lantheus
LNTH
$3.75B
| – | – |
-40,000
| Closed | -$2.48M |
|
91
Pulmonx
LUNG
$67.6M
| – | – |
-25,000
| Closed | -$319K |
|
92
MeiraGTx Holdings
MGTX
$590M
| – | – |
-32,091
| Closed | -$225K |
|
93
Pfizer
PFE
$141B
| – | – |
-580,000
| Closed | -$16.7M |
|
94
West Pharmaceutical
WST
$17.9B
| – | – |
-9,000
| Closed | -$3.17M |
|
|
AXNX
95
DELISTED
Axonics, Inc. Common Stock
AXNX
| – | – |
-220,000
| Closed | -$13.7M |
|